论文部分内容阅读
My talk includes the following topics: (1) Development of grapnene.oxiae (GO)-based nanovectors for targeted drug delivery.We demonstrated that folic acid-modified GO loaded with two anticancer drugs, DOX and CPT, shows specific targeting to MCF-7 cancer cells, and remarkably high cytotoxicity compared to GO loaded with only one drug.